Trial site
Rady Children's Hospital
- 35running trials
- 8closed trials
The trials here
What the 43 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers22 trials
- Neuroblastoma6 trials
- Acute lymphoblastic leukaemia4 trials
- Sarcoma3 trials
- Type 2 diabetes3 trials
- Acute myeloid leukaemia2 trials
- Congenital heart disease2 trials
- Glioblastoma2 trials
- Hearing loss2 trials
- Deep vein thrombosis and pulmonary embolism1 trial
- Duchenne muscular dystrophy1 trial
- Eosinophilic oesophagitis1 trial
- and 11 more
- Phase
- Phase 212 trials
- Phase 35 trials
- Phase 13 trials
- Phase 1/23 trials
- Early phase 11 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Recruiting20 trials
- Active, not recruiting12 trials
- Completed6 trials
- Enrolling by invitation2 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Giselle Sholler7 trials
- St. Jude Children's Research Hospital7 trials
- Children's Hospital Medical Center, Cincinnati2 trials
- Eli Lilly and Company2 trials
- Novartis Pharmaceuticals2 trials
- and 22 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Recruiting
Recruiting
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Enrolling by invitation
Recruiting
Recruiting
Active, not recruiting
Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Recruiting
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Recruiting
Recruiting
The Tether™ - Vertebral Body Tethering System Post Approval Study
Active, not recruiting
Active, not recruiting
Recruiting
Cardiotoxicity Assessment Through Comprehensive Heart Imaging to Predict Heart Failure
Active, not recruiting
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
Active, not recruiting
Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Active, not recruiting
Enrolling by invitation
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
Recruiting
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Recruiting
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Active, not recruiting
Recruiting
Active, not recruiting
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers11 recruiting
- Acute lymphoblastic leukaemia3 recruiting
- Neuroblastoma3 recruiting
- Acute myeloid leukaemia2 recruiting
- Congenital heart disease1 recruiting
- Duchenne muscular dystrophy1 recruiting
- Eosinophilic oesophagitis1 recruiting
- Haemophilia1 recruiting
- Hearing loss1 recruiting
- Heart failure1 recruiting
- Myelodysplastic syndromes1 recruiting
- Sarcoma1 recruiting
- Spinal muscular atrophy1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Withdrawn
Terminated
Completed
Completed
Completed
Fimepinostat in Treating Brain Tumors in Children and Young Adults
Completed
Completed
Completed
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer
Site data: ClinicalTrials.govUpdated 18 Nov 2026